CSF1r inhibitors for use in treating cancer

MYPI2025000985A0Undetermined Publication Date: 2020-06-28DECIPHERA PHARMACEUTICALS LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025000985
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-11-11
Filing Date
2019-12-23
Publication Date
2020-06-28
Patent Text Reader

Abstract

Described herein are CSF1R inhibitors for use in methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT). [Fig. 1]
Need to check novelty before this filing date? Find Prior Art